Asymmetric Catalysis with Chiral Salen Complexes
Asymmetric Catalysis with Chiral Salen Complexes
DOI 10.1007/b11772
1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
2 Salen Ligand Synthesis . . . . . . . . . . . . . . . . . . . . . . . . . . 124
3 Epoxidation Reactions . . . . . . . . . . . . . . . . . . . . . . . . . . 127
4 Epoxide Ring Opening Reactions . . . . . . . . . . . . . . . . . . . . 131
4.1 Hydrolytic Kinetic Resolution of Terminal Epoxides . . . . . . . . . 131
4.2 Other Nucleophilic Epoxide Opening Reactions . . . . . . . . . . . . 135
5 Carbonyl Addition Processes . . . . . . . . . . . . . . . . . . . . . . 141
6 Cycloaddition Processes . . . . . . . . . . . . . . . . . . . . . . . . . 145
6.1 Hetero-Diels-Alder Reaction . . . . . . . . . . . . . . . . . . . . . . . 145
6.2 Diels-Alder Reaction . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
6.3 Cyclopropanation Reaction . . . . . . . . . . . . . . . . . . . . . . . . 147
7 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
1
Introduction
The development of practical catalytic asymmetric processes for both laborato-
ry and industrial scale applications has been enabled greatly by the discovery of
a small number of ligands that exhibit high selectivity for a wide range of sub-
strates and over a broad spectrum of reactions [1]. This group of special ligands
includes BINAP and BINOL, tartaric acid derivatives, bis(oxazoline) and pybox
ligands, derivatives of the cinchona alkaloids, and the Duphos bis(phosphine)
ligands [2] (Fig. 1). Another member of this group of privileged ligands that has
emerged over the past several years is salen ligand 1. Metal complexes of ligand
1 have been successfully applied to a broad range of industrially important
asymmetric reactions. A survey of catalytic asymmetric reactions utilizing these
and related complexes and an evaluation of their utility within the pharmaceu-
tical and fine chemical industries is the focus of this review [3].
Fig. 1 Families of privileged ligands in asymmetric catalysis which show high product selec-
tivity and substrate generality for a number of different reactions
2
Salen Ligand Synthesis
Salen ligands are prepared by the condensation of two equivalents of a salicyla-
ldehyde derivative with a 1,2-diamine, and the simplest, achiral version (bold
structure in Fig. 1) is prepared from salicylaldehyde and ethylenediamine, ab-
breviations of which combine to give this ligand class its name. Chiral versions
of this tetradentate bis(imine) ligand are accessed simply by using chiral 1,2-di-
amines, although ligands derived from other diamines (1,3-, 1,4-, etc.) are often
Asymmetric Processes Catalyzed by Chiral (Salen)Metal Complexes 125
included in this class. Chiral salen ligands have several attractive features that
constitute the basis for their utility in asymmetric reactions. The salicylaldehyde
and diamine components are synthetically accessible and their condensation to
generate the salen ligand generally proceeds in nearly quantitative yield. Metal
complexes of salen ligands are readily prepared from a variety of first row and
second row transition metal salts as well as main group metals. Once the appro-
priate metal for the desired reactivity has been identified, the modularity of syn-
thesis of salen ligands allows for the systematic tuning of catalyst steric and elec-
tronic properties by modification of the metal counterion, the chiral diamine or
the salicylaldehyde components [4]. Although a large number of ligand struc-
tures are thus accessible, it is striking that salen ligand 1 has often been found to
be the optimum ligand for a broad range of reactions catalyzed by several differ-
ent metals (Fig. 2).
Fig. 3 Different structural variations of the salen ligand framework investigated for Mn-catalyzed asymmetric epox-
idation (AE)
[7, 8]. Due to the use of unnatural (-)-tartaric acid to isolate the (S,S)-diamine,
(S,S)-1 is slightly more expensive than (R,R)-1. The salicylaldehyde component
is prepared by formylation of 2,4-di-tert-butylphenol, which in turn is pro-
duced inexpensively on large scale by the double alkylation of phenol with iso-
butene.
Asymmetric Processes Catalyzed by Chiral (Salen)Metal Complexes 127
3
Epoxidation Reactions
The first example of enantioselective epoxidation of unfunctionalized olefins
catalyzed by chiral (salen)Mn(III) complexes was reported in 1990 [9], and this
remains an active area of study 12 years later. One of the more practical versions
of this asymmetric process utilizes Mn(III) complex 2 as the catalyst and aque-
ous bleach as the stoichiometric oxidant [5, 10]. Several subsequent variations
of ligand structure, metal center, and terminal oxidant have been developed, but
none have surpassed the utility and practicality of the process depicted in
Scheme 2. The epoxidation process generally requires an unsaturated conjugat-
Scheme 2 General conditions for asymmetric epoxidation (AE) of conjugated olefins cata-
lyzed by Mn complex 2
128 J. F. Larrow · E. N. Jacobsen
ing group such as an arene, alkene, or alkyne for acceptable reactivity. High
enantioselectivities are typically observed with most cis-1,2-disubstituted, as
well as certain tri- and tetrasubstituted olefins [11], while low-temperature, ho-
mogeneous conditions have been developed to access terminal epoxides in up to
86% ee [12]. trans Olefins yield epoxides in low enantiomeric excess, but condi-
tions have been developed that favor the production of high ee trans epoxides
from cis olefins [13]. The use of amine N-oxide additives such as 4-phenylpyri-
dine N-oxide (4-PPNO) can have a profound impact on the ratios of enantiomers
and cis/trans epoxides produced, and serve to improve the efficiency of the cat-
alyst [14]. These additives have been demonstrated to act as axial ligands that
bind to the Mn center trans to the oxo ligand [15].
Diastereomeric epoxide isomers (enantiomers in the case of terminal epox-
ides) are often obtained as primary products from isomerically pure cis-olefins.
This constitutes strong evidence for a mechanism of oxygen transfer from the
metal center to the olefin involving non-concerted formation of the C-O bonds.
Several plausible intermediates have been proposed to lie along this reaction path-
way, but at this stage there is mounting support, based on both experimental and
theoretical studies, for a radical pathway such as the one depicted in Fig. 4 [16].
The synthetic utility of the chiral (salen)Mn-catalyzed epoxidation reaction
has been demonstrated through several important examples. The asymmetric
epoxidation of cis-cinnamates was the key transformation in the practical syn-
thesis of the phenylisoserine side chain of Taxol [17] and in a route to the calci-
um channel antagonist Diltiazem (Scheme 3) [18]. Due to the problem of
cis/trans partitioning noted above, the asymmetric epoxidation process is most
Fig. 4 Stepwise mechanism of oxygen transfer from Mn to olefin leads to diastereomeric mix-
tures of epoxides
Asymmetric Processes Catalyzed by Chiral (Salen)Metal Complexes 129
Scheme 3 AE of cinnamates
Scheme 4 AE of chromenes
130 J. F. Larrow · E. N. Jacobsen
practical for the epoxidation of cyclic olefins where rotation is not possible.
Chromenes represent the best substrates for the AE reaction in terms of enanti-
oselectivity, and there are several pharmaceutically important derivatives of the
epoxides which have been accessed via this chemistry, including the anti-hyper-
tensive agents cromakalim, EMD-52,692, and BRL55834 (Scheme 4) [19].
The asymmetric epoxidation of indene has also been extensively studied be-
cause the epoxide can be transformed into cis-1-aminoindan-2-ol [20], an effec-
tive chiral ligand and an important portion of the HIV protease inhibitor Crix-
ivan [21]. In the optimized process for the epoxidation of indene [22], only
0.6 mol% catalyst was required using 3 mol% of additive, and the productivity
of the reaction was improved by using 10–14% NaOCl solution. For the scale-up
of this epoxidation, it was found that efficient mixing of the biphasic reaction
mixture was critical. Thus, the reaction reaches completion in less than 15 min-
utes if a blender is used. The epoxide is isolated in 84–86% ee by simple distilla-
tion, and is then converted to the cis-amino alcohol by a Ritter reaction followed
by hydrolysis. The enantiomeric excess of the product as well as the chemical pu-
rity are then upgraded by a recrystallization as the (+)-tartaric acid salt
(Scheme 5). An alternative route from indene oxide to aminoindanol involves
opening of the epoxide with ammonia followed by inversion at the 2-carbon via
an oxazoline intermediate [23]. This process has the advantage of using the less-
expensive (R,R)-2 as the catalyst, although the overall route involves more steps.
4
Epoxide Ring Opening Reactions
4.1
Hydrolytic Kinetic Resolution of Terminal Epoxides
Fig. 5 Representative epoxides successful in the hydrolytic kinetic resolution (HKR). Isolated yields reflect the amount of recov-
ered epoxide in >99% ee as a percentage of the amount of racemate input
4.2
Other Nucleophilic Epoxide Opening Reactions
The first asymmetric epoxide ring opening (ARO) reaction found to be cata-
lyzed by (salen)metal complexes was the desymmetrization of meso epoxides
with TMSN3 [43], discovered two years prior to the HKR. Meso epoxides under-
go desymmetrization catalyzed by (salen 1)Cr(III) complexes, with good-to-ex-
cellent enantioselectivity for epoxides derived from cyclic olefins, but lower se-
lectivity with acyclic meso epoxides. Best results were obtained with 5-mem-
bered ring substrates (entries 2, 4–5, 7), with lower but still useful ees observed
with cyclohexene oxide (entry 1). Larger ring epoxides performed poorly (en-
try 3), with cyclooctene oxide being completely unreactive (Table 1). The ARO
reaction was extended to the kinetic resolution of racemic terminal epoxides to
provide 1-azido-2-trimethylsiloxyalkane derivatives in high enantiomeric ex-
cess (Table 1, entries 9–18) [44] and of 2,2-disubstituted epoxides where the un-
reacted epoxides could be isolated in high ee [45]. Epoxide ring-opening with
TMSN3 has also been demonstrated to show a high degree of catalyst control in
the regioselective opening of enantiopure dissymmetrically substituted epox-
ides [46].
The ARO/KR reaction is usually run in the absence of solvent, and the prod-
uct can often be recovered in nearly quantitative yield by vacuum distillation.
The catalyst residue (4b) is recyclable, and as many as ten cycles have been dem-
onstrated. In this respect, the ARO reaction is very industrially practical since
two reactants combine to form one product with no waste using a highly selec-
tive, recyclable catalyst. However, commercialization of this technology has not
136 J. F. Larrow · E. N. Jacobsen
advanced due to the high capital costs inherent in the handling of azides on large
scale.
The primary synthetic utility of the ARO technology is in the preparation of
1,2-amino alcohols in which the oxygen and nitrogen groups are differentially
protected to facilitate further elaboration. Chiral amino alcohols have a rich his-
tory as asymmetric ligands and are a prominent pharmacophore in several
classes of drugs [47]. Both cis and trans amino alcohol products are accessible in
enantiopure form via the ARO of meso epoxides [48]. Several pharmaceutically
active compounds have been synthesized in the laboratory utilizing this technol-
ogy as the key asymmetric transformation (Fig. 7). The ARO desymmetrization
reaction was the key transformation in the synthesis of carbocyclic nucleoside
Asymmetric Processes Catalyzed by Chiral (Salen)Metal Complexes 137
Fig. 7 Biologically active compounds synthesized utilizing ARO or KR as the key asymmetric
transformation
analogues such as Carbovir useful in the treatment of viral infections [49]. Other
applications include key intermediates in the synthesis of prostaglandins [50];
allosamizoline, a component of the allosamidin family of chitinase inhibitors
[51]; Balanol, a natural product inhibitor of protein kinase C [52]; and the 1,2-
aziridinomitosene ring system of the mitomycin antitumor antibiotics [53]. The
kinetic resolution application was utilized in the synthesis of the b-blocker (S)-
propranolol and the antiviral agent (R)-PMPA [44], as well as the natural prod-
uct taurospongin A [54]. Epichlorohydrin was also found to undergo dynamic
kinetic resolution, yielding the product (S)-3-azido-1-chloro-2-trimethylsiloxy-
propane in 97% ee and 76% yield based upon racemic epoxide. This product was
utilized in the synthesis of the novel aryl oxazolidinone antibiotic U-100592
[55].
The ARO displays similar kinetic behavior to the HKR in that it is subject to
a second-order dependence on catalyst concentration; a similar bimetallic
mechanism involving simultaneous activation of nucleophile and electrophile
by distinct catalyst molecules has been postulated for both reactions [56, 57].
Benzylic thiol nucleophiles work best with (salen)Cr complexes, but moderate
levels of enantioselectivity limit the utility of this methodology [58]. Halides
138 J. F. Larrow · E. N. Jacobsen
have shown excellent reactivity as nucleophiles with both catalyst systems, but
enantioselectivities are generally low. Recently, complex 4a has been reported to
be a competent promoter of the enantioselective opening of epoxides with fluo-
ride, but the efficiency of catalysis is poor and the mechanism is unclear [59].
The ARO of meso epoxides with benzoic acid catalyzed by (salen)Co(III) com-
plexes displayed good-to-excellent levels of enantioselectivity, and the highest
ees were obtained with aromatic substituted epoxides such as cis-stilbene oxide
[60]. Although the kinetic resolution of racemic terminal epoxides with carbox-
ylic acid derivatives was not preparatively useful, catalytic regioselective open-
ing of resolved epoxides can be accomplished with most carboxylic acids. This
strategy has been effectively utilized to prepare glycidyl butyrate by opening re-
solved epichlorohydrin with butyric acid followed by ring closure of the chloro-
hydrin to the epoxide (Scheme 7).
Scheme 9 Potential industrial routes to the key intermediate in the synthesis of the quinolone
antibiotic levofloxacin
As with the HKR reaction, the ring opening of epoxides with these other nu-
cleophiles has been rendered significantly more practical from an industrial
perspective by the development of the oligomeric (salen)Co catalysts. These cat-
alysts again display enhanced reactivity and selectivity with these nucleophiles
relative to the monomeric catalysts (Table 2). This is even more important with
nucleophiles other than water because higher loadings of the monomeric and ol-
igomeric catalysts are generally required for these reactions. In this context, the
synthetic accessibility of the oligo(salen) catalysts becomes the paramount issue
because the cost contribution of the catalyst to the product is no longer negligi-
ble as it is in the HKR example described in the previous section. In addition, the
range of useful nucleophiles has been expanded to include primary alcohols (en-
tries 4–5), which are effectively unreactive with the monomeric catalysts [66].
Oligo(salen) complexes of metals other than Co(III) have yet to be evaluated, but
enhanced performance and an expansion of the pool of useful reactions can be
reasonably anticipated.
In summary, chiral (salen)Co(III) and Cr(III) complexes have been found to
catalyze the asymmetric ring opening of meso and racemic terminal epoxides
with a high degree of selectivity using a variety of synthetically useful nucle-
140 J. F. Larrow · E. N. Jacobsen
Table 2 Comparison of monomeric and oligomeric catalysts in KR and ARO of epoxides with
hydroxylic nucleophiles
ophiles. Novel cyclic oligo(salen) catalysts have also shown remarkable en-
hancement in reactivity and selectivity relative to monomeric catalysts, leading
to the prospect of additional reactions catalyzed by these complexes. Interest-
ingly, despite a great deal of effort, cyanide and other carbon nucleophiles were
completely unreactive with these catalysts [67]. However, with an overwhelming
body of evidence supporting a cooperative bimetallic mechanism for nucle-
ophilic epoxide opening reactions by simultaneous activation of the nucleophile
and the epoxide by distinct catalytic centers, the question of whether or not this
mechanism was general for a broader range of nucleophile-electrophile reac-
Asymmetric Processes Catalyzed by Chiral (Salen)Metal Complexes 141
5
Carbonyl Addition Processes
Because of its great synthetic significance and the fact that it utilizes a novel nu-
cleophile-electrophile pair, the addition of hydrogen cyanide to imines (the
Strecker reaction) was chosen as an ambitious target for asymmetric catalysis by
chiral (salen)metal complexes. The asymmetric Strecker reaction provides facile
access to optically active a-amino acids, but progress in this area was limited un-
til very recently [68]. In the current study, a series of metal complexes of salen 1
were screened for catalysis of the reaction of N-allyl benzaldimine with trimeth-
ylsilylcyanide. Several (salen)metal complexes were found to catalyze the reac-
tion with varying degrees of conversion and enantioselectivity, and the best re-
sults were observed with the Al complex 5a [69]. The actual reactive reagent in
the reaction was determined to be HCN, which could be conveniently generated
in situ from TMSCN and methanol. In order to suppress the racemic back-
ground reaction, the reactions were performed at -70 °C, and the products were
trifluoroacetylated to prevent racemization. A variety of alkyl and aryl N-allyl
imines were evaluated in the reaction, and substituted aryl imines gave the high-
est levels of enantioselectivity (Scheme 10). Alkyl imines yielded products with
more modest ees. Modification of the nitrogen substituent of the imine or of the
steric or electronic properties of the salen ligand proved unsuccessful in improv-
ing the results with these synthetically useful substrates. However, a novel non-
metal catalyst (7) was identified which provided excellent selectivities with all
types of imine structures [70].
Among the (salen)metal complexes found to be active for the addition of cy-
anide to imines was the Ti(IV)Cl2 complex of ligand 1. This complex was previ-
ously identified by North and Belokon as an asymmetric catalyst for the addition
of TMSCN to aldehydes [71] and ketones [72]. In a limited screening of salen lig-
and substituents, ligand 1 was found to be optimum for this transformation as
well. Subsequently, the Ti(IV)oxo-dimer (8) and the V(IV)oxo (9) complexes of
ligand 1 were determined to be improved catalysts in terms of reactivity (8) or
selectivity (9) for all substrates investigated (Scheme 11) [73]. Like the
(salen)Al-catalyzed addition of HCN to imines, aromatic aldehydes were the
best substrates, although a greater range of selectivities was observed.
of allylic and propargylic halides with aromatic aldehydes (Scheme 13) [76]. The
use of 1,3-dichloropropene has also been investigated as a route to optically ac-
tive vinyl epoxides [77]. Despite being much less developed than alternative tin-
and silicon-based chemistry [78], this work has the advantage of directly utiliz-
ing allylic and propargylic halides from which the corresponding stannanes and
silanes are typically prepared. At this stage, the practical application of these re-
actions is limited by the moderate-to-low yields due to competing side reactions,
the long reaction times, and the requirement of high catalyst loadings (typically
10 mol% plus excess ligand).
144 J. F. Larrow · E. N. Jacobsen
6
Cycloaddition Processes
6.1
Hetero-Diels-Alder Reaction
6.2
Diels-Alder Reaction
edented catalytic activity (requiring as little as 0.05 mol% catalyst) [86]. Cata-
lysts (11) possessing trialkylsilyl groups at the 3,3¢-positions showed greater re-
activity and selectivity than Co complex 3c.
6.3
Cyclopropanation Reaction
7
Conclusion
Over the past decade, chiral (salen)metal complexes have emerged as versatile
catalysts for a broad range of industrially and academically interesting reac-
tions. Since its discovery as an optimum ligand for (salen)Mn-catalyzed asym-
metric epoxidation reactions in 1991 [5], metal complexes of salen ligand 1 have
displayed remarkable effectiveness in a wide variety of catalytic asymmetric re-
actions. Ligand 1 and its metal complexes are available commercially at relative-
ly low cost, and the Mn-catalyzed asymmetric epoxidation and Co-catalyzed hy-
drolytic kinetic resolution processes are currently practiced on industrial scale.
In addition, new discoveries such as the extraordinarily high levels of reactivity
and selectivity observed with the oligomeric (salen)Co complexes in epoxide
ring opening reactions portend a continued bright future for salen ligands in
asymmetric catalysis. As insight is gleaned into the factors controlling reactivity
and stereoselection, rational design of improved ligands becomes likely. Howev-
er, at this stage, salen ligand 1 still defines the standard by which others are eval-
uated.
References
1. For comprehensive coverage of the field of asymmetric catalysis see: Pfaltz A, Jacobsen
EN, Yamamoto H (eds) (1999) Comprehensive asymmetric catalysis, vols 1–3. Spring-
er, Berlin Heidelberg New York
2. For an historical review of asymmetric catalysis which discusses most of these ligand
families, see: Kagan H (1999) Historical perspective. In: Pfaltz A, Jacobsen EN,
Yamamoto H (eds) Comprehensive asymmetric catalysis, vol 1. Springer, Berlin Hei-
delberg New York, chap 2
3. Due to space limitations, salen ligands derived from chiral salicylaldehydes and/or
from diamines other than 1,2-diamines will not be discussed extensively in this review.
Asymmetric Processes Catalyzed by Chiral (Salen)Metal Complexes 149
For lead references of applications utilizing ligands of this type, see: (a) Katsuki T
(1995) Coord Chem Rev 140:189; (b) Ito YN, Katsuki T (1999) Bull Chem Soc Jpn
72:603; (c) Katsuki T (2002) Adv Synth Catal 344:131
4. (a) Jacobsen EN, Zhang W, Güler ML (1991) J Am Chem Soc 113:6703; (b) Palucki M,
Finney NS, Pospisil PJ, Güler ML, Ishida T, Jacobsen EN (1998) J Am Chem Soc 120:948
5. Jacobsen EN, Zhang W, Muci AR, Ecker JR, Deng L (1991) J Am Chem Soc 113:7063
6. (a) Jacobsen EN (1993) Asymmetric catalytic epoxidation of unfunctionalized olefins
In: Ojima I (ed) (1993) Catalytic asymmetric synthesis, 1st edn. Wiley-VCH, New York,
chap 4.2; (b) Jacobsen EN (1995) Transition metal-catalyzed oxidations: asymmetric
epoxidation In: Wilkinson G, Stone FGA, Abel EW, Hegedus LS (eds) (1995) Compre-
hensive organometallic chemistry, 2nd edn, vol 12. Pergamon, New York, pp 1097–
1135; (c) Jacobsen EN, Wu MH (1999) Epoxidation of alkenes other than allylic alco-
hols In: Pfaltz A, Jacobsen EN, Yamamoto H (eds) (1999) Comprehensive asymmetric
catalysis, vol 2. Springer, Berlin Heidelberg New York, chap 18.2; (d) Also see [3]
7. (a) Larrow JF, Jacobsen EN, Gao Y, Hong Y, Nie X, Zepp CM (1994) J Org Chem 59:1939;
(b) Larrow JF, Jacobsen EN (1997) Org Syn 75:1
8. Gasbøl F, Steenbøl P, Sørensen BS (1972) Acta Chem Scand 26:3605
9. Zhang W, Loebach JL, Wilson SR, Jacobsen EN (1990) J Am Chem Soc 112:2801
10. Zhang W, Jacobsen EN (1991) J Org Chem 56:2296
11. (a) Brandes BD, Jacobsen EN (1994) J Org Chem 59:4378; (b) Fukuda T, Irie R, Katsuki
T (1995) Synlett 197; (c) Brandes BD, Jacobsen EN (1995) Tetrahedron Lett 36:5123
12. (a) Palucki M, Pospisil PJ, Zhang W, Jacobsen EN (1994) J Am Chem Soc 116:9333; (b)
Palucki M, McCormick GJ, Jacobsen EN (1995) Tetrahedron Lett 36:5457
13. (a) Lee NH, Jacobsen EN (1991) Tetrahedron Lett 32:6533; (b) Chang S, Galvin JM,
Jacobsen EN (1994) J Am Chem Soc 116:6937
14. (a) Irie R, Ito Y, Katsuki T (1991) Synlett 265; (b) Irie R, Noda K, Ito Y, Matsumoto N,
Katsuki T (1991) Tetrahedron: Asymmetry 2:481; (c) Also see [15]
15. (a) Finney NS, Pospisil PJ, Chang S, Paluki M, Konsler RG, Hansen KB, Jacobsen EN
(1997) Angew Chem Int Ed Engl 36:1720; (b) Senanayake CH, Smith GB, Ryan KM, Fre-
denburgh LE, Liu J, Roberts FE, Hughes DL, Larsen RD, Verhoeven TR, Reider PJ
(1996) Tetrahedron Lett 37:3271
16. See [6c]. For an overview of the various mechanistic proposals, see: Linker T (1997)
Angew Chem Int Ed Engl 36:2060
17. Deng L, Jacobsen EN (1992) J Org Chem 57:4320
18. Jacobsen EN, Deng L, Furukawa Y, Martínez LE (1993) Tetrahedron 50:4323
19. (a) Bell D, Davies MR, Finney FJL, Geen GR, Kincey PM, Mann IS (1996) Tetrahedron
Lett 37:3895; (b) Lee NH, Muci AR, Jacobsen EN (1991) Tetrahedron Lett 32:5055
20. (a) Hughes DL, Smith GB, Liu J, Dezeny GC, Senanayake CH, Larsen RD, Verhoeven
TR, Reider PJ (1997) J Org Chem 62:2222; (b) For a review of this compound, see: Sen-
anayake CH (1998) Aldrichimica Acta 31:3
21. (a) Vacca JP, Dorsey BD, Schleif WA, Levin RB, McDaniel SL, Darke PL, Zugay J, Quin-
tero JC, Blahy OM, Roth E, Sardana VV, Schlabach AJ, Graham PI, Condra JH, Gotlib L,
Holloway MK, Lin J, Chen I-W, Vastag K, Ostovic D, Anderson PS, Emini EA, Huff JR
(1994) Proc Natl Acad Sci USA 91:4096; (b) Dorsey BD, Levin RB, McDaniel SL, Vacca
JP, Guare JP, Darke PL, Zugay JA, Emini EA, Schleif WA, Quintero JC, Lin JH, Chen I-
W, Holloway MK, Fitzgerald PMD, Axel MG, Ostovic D, Anderson PS, Huff JR (1994) J
Med Chem 37:3443
22. (a) Larrow JF, Roberts E, Verhoeven TR, Ryan KM, Senanayake CH, Reider PJ, Jacobsen
EN (1999) Org Syn 76:46; (b) Also see [20a]
23. Gao Y, Hong Y, Nie X, Bakale RP, Feinberg RR, Zepp CM (1997) US Patent 559,998,518
24. (a) Bousquet C, Gilheaney DG (1995) Tetrahedron Lett 36:7739; (b) Ryan KM, Bous-
quet C, Gilheaney DG (1999) Tetrahedron Lett 40:3613; (c) Daly AM, Dalton CT, Rene-
han MF, Gilheaney DG (1999) Tetrahedron Lett 40:3617; (d) Daly AM, Renehan MF,
Gilheaney DG (2001) Org Lett 3:663
150 J. F. Larrow · E. N. Jacobsen
25. O’Mahoney CP, McGarrigle EM, Renehan MF, Ryan KM, Kerrigan NJ, Bousquet C, Gil-
heaney DG (2001) Org Lett 3:3435
26. (a) Takeda T, Irie R, Shinoda Y, Katsuki T (1999) Synlett 1157; (b) Nakata K, Takeda T,
Mihara J, Hamada T, Irie R, Katsuki T (2001) Chem Eur J 7:3776
27. Benzylic hydroxylation: (a) Larrow JF, Jacobsen EN (1994) J Am Chem Soc 116:12,129;
(b) Hamachi K, Irie R, Katsuki T (1996) Tetrahedron Lett 37:4979; (c) Hamada T, Irie
R, Mihara J, Hamachi K, Katsuki T (1998) Tetrahedron 54:10,017; (d) Komiya N, Noji
S, Murahashi SI (1998) Tetrahedron Lett 39:7921. Oxidation of a-carbons in heterocy-
cles: (e) Miyafuji A, Katsuki T (1997) Synlett 836; (f) Miyafuji A, Katsuki T (1998) Tet-
rahedron 54:10,339; (g) Punniyamurthy T, Miyafuji A, Katsuki T (1998) Tetrahedron
Lett 39:8295; (h) Punniyamurthy T, Katsuki T (1999) Tetrahedron 55:9439. Benzylic
amination: (i) Kohmura Y, Katsuki T (2001) Tetrahedron Lett 42:3339
28. Mn-catalyzed: (a) Palucki M, Hanson P, Jacobsen EN (1992) Tetrahedron Lett 33:7111;
(b) Kokubo C, Katsuki T (1996) Tetrahedron 52:13,895. Ti-catalyzed: (c) Saito B, Kat-
suki T (2001) Tetrahedron Lett 42:3873; (d) Saito B, Katsuki T (2001) Tetrahedron Lett
42:8333; (e) Sasaki C, Nakajima K, Kojima M, Fujita J (1991) Bull Chem Soc Jpn
64:1318. V-catalyzed: (f) Nakajima K, Kojima K, Kojima M, Fujita J (1990) Bull Chem
Soc Jpn 63:2620
29. (a) Nishikori H, Katsuki T (2000) Appl Catal A 194/195:475; (b) Ohta C, Katsuki T
(2001) Tetrahedron Lett 42:3885; (c) Murakami M, Uchida T, Katsuki T (2001) Tetrahe-
dron Lett 42:7071; (d) Nishikori H, Ohta C, Oberlin E, Irie R, Katsuki T (1999) Tetrahe-
dron 55:13,937
30. Uchida T, Katsuki T (2001) Tetrahedron Lett 42:6911
31. (a) Johnson RA, Sharpless KB (2000) Catalytic asymmetric epoxidation of allylic alco-
hols In: Ojima I (ed) (2000) Catalytic asymmetric synthesis, 2nd edn. Wiley-VCH, New
York, chap 6A; (b) Also see Bolm C (1991) Angew Chem Int Ed Engl 30:403
32. (a) Parker RE, Isaacs NS (1959) Chem Rev 59:737; (b) Behrens CH, Sharpless KB (1983)
Aldrichimica Acta 16:67; (c) Hansen RM (1991) Chem Rev 91:437
33. For the most enantioselective methods developed involving synthetic catalysts, see: (a)
[12a]; (b) Collman JP, Wang Z, Straumanis A, Quelquejeu M, Rose E (1999) J Am Chem
Soc 121:460
34. (a) Tokunaga M, Larrow JF, Kakiuchi F, Jacobsen EN (1997) Science 277:936; (b) Fur-
row ME, Schaus SE, Jacobsen EN (1998) J Org Chem 63:6776
35. For a review of criteria for practical kinetic resolutions, see: Keith JM, Larrow JF,
Jacobsen EN (2001) Adv Synth Catal 343:5
36. Schaus SE, Brandes BD, Larrow JF, Tokunaga M, Hansen KB, Gould AE, Furrow ME,
Jacobsen EN (2002) J Am Chem Soc 124:1307
37. Hong J, Blackmond DG, Jacobsen EN (manuscript in preparation)
38. (a) Johnson DW, Singleton DA (1999) J Am Chem Soc 121:9307; (b) Blackmond DG
(2001) J Am Chem Soc 123:545
39. Konsler RG, Karl J, Jacobsen EN (1998) J Am Chem Soc 120:6776
40. (a) Annis DA, Jacobsen EN (1999) J Am Chem Soc 121:4147; (b) Breinbauer R, Jacobsen
EN (2000) Angew Chem Int Ed 39:3604
41. Ready JM, Jacobsen EN (2001) J Am Chem Soc 123:2687
42. Ready JM, Jacobsen EN (2002) Angew Chem Int Ed 41:1374
43. Martinéz LE, Leighton JL, Carsten DH, Jacobsen EN (1995) J Am Chem Soc 117:5897
44. Larrow JF, Schaus SE, Jacobsen EN (1996) J Am Chem Soc 118:7420
45. Lebel H, Jacobsen EN (1999) Tetrahedron Lett 40:7303
46. Brandes BD, Jacobsen EN (2001) Synlett 1013
47. For leading examples, see: Lednicer D (1998) Strategies for organic drug synthesis and
design. Wiley-Interscience, New York
48. Schaus SE, Larrow JF, Jacobsen EN (1997) J Org Chem 62:4197
49. Martinéz LE, Nugent WA, Jacobsen EN (1996) J Org Chem 61:7963
50. Leighton JL, Jacobsen EN (1996) J Org Chem 61:389
Asymmetric Processes Catalyzed by Chiral (Salen)Metal Complexes 151
80. Evans DA, Janey JM, Magomedov N, Tedrow JS (2001) Angew Chem Int Ed 40:1884
81. DiMauro EF, Kozlowski MC (2001) Org Lett 3:3053. See also: Cozzi PG, Papa A, Umani-
Ronchi A (1996) Tetrahedron Lett 37:4613
82. Schaus SE, Branalt J, Jacobsen EN (1998) J Org Chem 63:403. See also: (a) Schaus SE,
Branalt J, Jacobsen EN (1998) J Org Chem 63:4876; (b) Aikawa K, Irie R, Katsuki T
(2001) Tetrahedron 57:845; (c) Mihara J, Aikawa K, Uchida T, Irie R, Katsuki T (2001)
Heterocycles 54:395
83. (a) Keck GE, Li XY, Krishnamurthy D (1995) J Org Chem 60:5998; (b) Corey EJ, Cywin
CL, Roper TD (1992) Tetrahedron Lett 33:6907
84. Dossetter AG, Jamison TF, Jacobsen EN (1999) Angew Chem Int Ed 38:2398. For syn-
thetic applications, see: (a) Thompson CF, Jamison TF, Jacobsen EN (2000) J Am Chem
Soc 122:10,482; (b) Chavez DE, Jacobsen EN (2001) Angew Chem Int Ed 40:3667
85. (a) Huang Y, Iwama T, Rawal VH (2000) J Am Chem Soc 122:7843; (b) Huang Y, Iwama
T, Rawal VH (2002) Org Lett 4:1163. For synthetic application, see: (c) Kozmin SA, Iwa-
ma T, Huang Y, Rawal VH (2001) J Am Chem Soc 124:4628
86. Huang Y, Iwama T, Rawal VH (2002) J Am Chem Soc 124:5950
87. (a) Fukuda T, Katsuki T (1995) Synlett 3:825; (b) Fukuda T, Katsuki T (1997) Tetrahe-
dron 53:7201
88. (a) Uchida T, Irie R, Katsuki T (1999) Synlett 7:1163; (b) Uchida T, Irie R, Katsuki T
(1999) Synlett 7:1793; (c) Uchida T, Irie R, Katsuki T (2000) Tetrahedron 56:3501; (d)
Yao X, Qiu M, Lu W, Chen H, Zheng Z (2001) Tetrahedron: Asymmetry 12:197
89. (a) Niimi T, Uchida T, Irie R, Katsuki T (2000) Tetrahedron Lett 41:3647; (b) Niimi T,
Uchida T, Irie R, Katsuki T (2001) Adv Synth Catal 343:79; (c) Uchida T, Saha B, Katsuki
T (2001) Tetrahedron Lett 42:2521
90. (a) Pfaltz A (1999) Cyclopropanation and CH insertion with Cu In: Pfaltz A, Jacobsen
EN, Yamamoto H (eds) (1999) Comprehensive asymmetric catalysis, vol 2. Springer,
Berlin Heidelberg New York, chap 16.1; (b) Lydon KM, McKervey MA (1999) Cyclopro-
panation and CH insertion with Rh In: Pfaltz A, Jacobsen EN, Yamamoto H (eds)
(1999) Comprehensive asymmetric catalysis, vol 2. Springer, Berlin Heidelberg New
York, chap 16.2; (c) Charette AB, Lebel H (1999) Cyclopropanation and CH insertion
with metals other than Cu and Rh. In: Pfaltz A, Jacobsen EN, Yamamoto H (eds) (1999)
Comprehensive asymmetric catalysis, vol 2. Springer, Berlin Heidelberg New York,
chap 16.3